the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories
Japanese Korean

[Report]

Trends in Cell Therapeutics: Promise and Reality

Published: 2004/03

Contact 24 hrs/day
Description

Table of Contents

CHAPTER ONE: Executive Summary

  • Scope and Methodology
  • Size and Growth of the Market
  • Market Trends

CHAPTER TWO: Introduction

  • Cell Therapy?Past, Present, and Future
  • A Word About Stem Cells
  • Disease Opportunities and Scientific Reticence
  • Point of View

CHAPTER THREE: Cell Technology Commercialization: The Journey from Bench to Clinic

  • Problems with Embryonic Stem Cells: It's More than Ethics
  • Adult Stem Cells to the Rescue?
  • Autologous, Allogeneic, and Xenogenic Products
  • Cell Therapy Equipment and Accessories
  • Cloning and Bioengineering Cells and Tissues
  • The Journey Continues

CHAPTER FOUR: Market Trends and Issues Population Demographics and The Demand for Cell and Tissue Products

  • Patent Issues
  • Technology and Reimbursement Issues
  • New Technology Commercialization
  • Regulatory Affairs
    • The European Union
    • Germany
    • France
    • Spain
    • United Kingdom
    • Sweden
    • Japan
    • China
    • Singapore
    • Israel
    • Canada
    • Australia
    • United States

CHAPTER FIVE: Cell Therapy Applications: Commercial and Non-Commercial Research

  • Cancer Vaccines
  • Cardiovascular Diseases
  • Diabetes
  • Electronic Tissue
  • Gene / Drug Delivery
  • Immune System Modulation
  • Nervous System Injuries / Neurological Diseases
  • Organ Replacement / Tissue Engineering
  • Miscellaneous Applications

CHAPTER SIX: Market Analysis

  • Introduction
  • Bioengineered Skin Products
  • Bone and Cartilage
  • Stem Cell Therapy, 2002-2007
  • Cell therapy, 2005-2015
  • Company Mergers and Closures
  • Cell Cloning

CHAPTER SEVEN: Conclusions and Strategic Implications

  • First Conclusion
  • Implication
  • Second Conclusion
  • Implication
  • Third Conclusion
  • Implication
  • Fourth Conclusion
  • Implication
  • Fifth Conclusion
  • Implication

CHAPTER EIGHT: Companies and Technologies To Watch

CHAPTER NINE: Company Profiles

  • Aastrom Biosciences, Inc.
  • Advanced Cell Technology (ACT)
  • AmCyte Inc.
  • Anthrogenesis (Acquired by Celgene Corp.)
  • Artecel Inc. (formerly Artecel Sciences, Inc.)
  • Athersys Inc.
  • Baxter Healthcare Corporation
  • Bioheart Inc.
  • BresaGen Ltd.
  • Celgene Corporation
  • Cell Transplants International, LLC (CTI)
  • Celmed BioSciences Inc.
  • Chromos Molecular Systems Inc.
  • Diatranz, Ltd.
  • ES Cell International Pte Ltd (ESI)
  • Gamida-Cell Ltd.
  • GenVec Inc. / Diacrin
  • Geron Corporation
  • Immuno-Designed Molecules S.A. (IDM)
  • Kourion Therapeutics
  • LifeCell Corporation
  • Merix Bioscience, Inc.
  • MicroIslet Inc.
  • Nucleotech LLC
  • Osiris Therapeutics Inc.
  • Proneuron Biotechnologies Inc.
  • Transition Therapeutics Inc.
  • ViaCell, Inc.
  • Xcyte Therapies, Inc

APPENDIX A: List of Cell Therapy Companies and Their Products

APPENDIX B: Lexicon of Cell Therapy Terms

List of Exhibits

CHAPTER THREE: Cell Technology Commercialization: The Journey from Bench to Clinic

  • Table 3-1: Providers of Currently Approved Cell Lines
  • Table 3-2: Selected Companies Working on Adult and Stem Cell Therapies
  • Table 3-3: Selected Cell Encapsulated Cell Therapeutics
  • Table 3-4: Selected Cell Therapy Products using Xenogenic Cells
  • Table 3-5: Selected Cell Therapy Equipment and Accessories
  • Table 3-6: Selected Cell and Tissue Bioengineered Products

CHAPTER FIVE: Cell Therapy Applications: Commercial and Non-Commercial Research

  • Table 5-1: Selected Cancer Vaccine Programs
  • Table 5-2: Selected Stem Cell Therapies for Cardiovascular Disease
  • Table 5-3: Selected Diabetes Cell Therapy Products
  • Table 5-4: Selected Neural Stem Cell Therapies
  • Table 5-5: Selected Organ Bioengineering Programs

CHAPTER SIX: Market Analysis

  • Table 6-1: Number of Patients in Selected Cell Therapy Target Populations in the United States
  • Table 6-2: Worldwide Market for Selected Cell Therapies by Type 2002-2007
  • Table 6-3: Sales of the Leading Skin Replacement Products 2002
  • Table 6-4: Cell Replacement Procedures by Region 2002-2007
  • Figure 6-1: Technology Penetration Forecast for Cell Therapy Technologies

CHAPTER EIGHT: Companies and Technologies to Watch

  • Table 8-1: Strength Analysis of 22 Selected Cell Therapy Companies
  • Table 8-2: Kalorama's Short List of Cell Therapy Companies
Description

[Report]
Trends in Cell Therapeutics: Promise and Reality
Published: 2004/03
Published by : Kalorama Information Kalorama Information

Price:
US $ 3,500.00 Hard Copy
US $ 3,500.00 PDF by E-mail (Single User License)
US $ 3,800.00 PDF by E-mail (Single User License) & Hard Copy
US $ 7,000.00 PDF by E-mail (Corporate License)
>
Product Code : KL18432
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.